Showing results 1 to 1 of 1
| Issue Date | Title | Journal Title |
|---|---|---|
| 2026 | Tucatinib and trastuzumab emtansine for patients with previously treated HER2-positive locally advanced and metastatic breast cancer: primary analysis of the randomized phase III trial HER2CLIMB-02 | ANNALS OF ONCOLOGY |